AzTrials
AzTrials

CholelithiasisPhase 3NCT01558414

Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery for Cholecystectomy

A Phase 3 study testing SILS Cholecystectomy, FSIS cholecystectomy and Conventional laparoscopy in people with Cholelithiasis and Surgery, run by Jose F. Noguera at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Prospective randomized pilot clinical trial, with 3 arms and one year follow up. The study will include 60 patients, with a 1:1:1 ratio, 20 patients per group. In 40 patients a transumbilical single site incision will be performed with two different manners: single-port device SILS TM (Single Incision Laparoscopic… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Cholelithiasis, Surgery, Laparoscopy
What is being tested?
SILS Cholecystectomy, FSIS cholecystectomy and Conventional laparoscopy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
Apr 2011to Nov 2012
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age over 18 and under 65
  • symptomatic cholelithiasis with an indication for laparoscopic surgery
  • signed specific informed consent including specific information of the new surgical approach
  • ASA 1 and 2.

Who cannot join

  • current or previous cholecystitis
  • current or previous suspected bile duct's problems
  • previous abdominal surgery
  • umbilical and other abdominal hernias
  • some other condition with increased risk to infection or abdominal wall problems.
  • ASA 3 and more

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Son Llàtzer

    Palma de Mallorca, Balearic Islands, 07198

Other trials in Spain

About this study

Official title: Prospective Randomized Clinical Trial Comparing Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery on Cholecystectomy

Prospective randomized pilot clinical trial, with 3 arms and one year follow up. The study will include 60 patients, with a 1:1:1 ratio, 20 patients per group. In 40 patients a transumbilical single site incision will be performed with two different manners: single-port device SILS TM (Single Incision Laparoscopic Surgery), and flexible endoscope and accessory trocars in a single incision (FSIS-Flexible Single Incision Surgery). The third group is the control one, a conventional laparoscopic approach.

The trial is designed as a pilot study to assess, as main objective, if these two endoscopic approaches have the same security and effectiveness in cholecystectomy.

Read more

Hypothesis:

Transumbilical approaches with single port and single incision with the flexible endoscope have the same efficacy and safety performing the endoscopic cholecystectomy.

Objectives:

Main objective:

Assess whether both approaches are equally safe in its application to endoscopic cholecystectomy.

Secondary objectives:

Investigate the differences in the rate of conversion to open surgery between different surgical approaches.

Investigate the differences in the rate of wound infection between the different surgical approaches.

Investigate the differences in the rate of postoperative incisional hernias between different surgical approaches.

Investigate whether there are differences in the rate of overall complications, all-cause mortality and the cost between different surgical approaches.

Read the detailed description

Inclusion criteria:

  • Patients affected with symptomatic cholelithiasis with elective surgical indication, not urgent, aged between 18 and 65.
  • Signing of informed consent for cholecystectomy and specific consent for the trial.
  • Anesthetic risk ASA I-II.

Exclusion criteria:

  • Presence of acute cholecystitis and / or suspicion of occupation of the main bile duct.
  • ASA III and higher.
Being tested
SILS Cholecystectomy, FSIS cholecystectomy, Conventional laparoscopy
Keywords
Cholecystectomy, Minimally invasive surgery, Laparoscopic surgery, Single incision surgery
Medical subject headings
Cholelithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SILS CholecystectomyProcedure or surgery

    Cholecystectomy performed by Single Incision Laparoscopic Surgery with the SILS TM device

  • FSIS cholecystectomyProcedure or surgery

    Cholecystectomy performed by Flexible Single Incision Surgery with the flexible endoscope through a single incision at the umbilicus

  • Conventional laparoscopyProcedure or surgery

    Minimally invasive cholecystectomy through the conventional laparoscopic approach using 3 ports (one 11-cm umbilical port and two accessory 5-mm ports).

Study groups in NCT01558414
Study groupRoleWhat they receive
SILSExperimentalCholecystectomy performed by Single Incision Laparoscopic Surgery with the SILS TM device
Receives: Procedure: SILS Cholecystectomy
FSISExperimentalCholecystectomy performed by Flexible Single Incision Surgery with the flexible endoscope through a single incision at the umbilicus
Receives: Procedure: FSIS cholecystectomy
Conventional laparoscopyActive comparatorCholecystectomy performed by a conventional laparoscopic approach
Receives: Procedure: Conventional laparoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical safety

    Number of patients without clinical problems in the surgery

    Measured: During surgical intervention

Secondary outcomes (1)
  1. Conversion to other surgical approach

    Rate of conversion to conventional laparoscopic surgery and open surgery.

    Measured: During the surgical intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2012 (estimated)
  2. Study startApr 2011
  3. Primary completionOct 2011
  4. Study completionNov 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01558414
Sponsor's protocol ID
Llatzer-FSIS
Status last verified
Mar 2013
First submitted
17 Mar 2012
Last updated
12 Mar 2013
Results posted
No
Data monitoring committee
No

Publications

  • Sanchez-Margallo FM, Perez FJ, Sanchez MA, Asencio JM, del Carmen Tejonero M, Moreno C, Noguera J. Hybrid notes cholecystectomy in an experimental model of laparoscopic acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2011 Apr;21(2):e65-9. doi: 10.1097/SLE.0b013e31820a2079.

    PubMed 21471782
  • Noguera JF, Cuadrado A, Sanchez-Margallo FM, Dolz C, Asencio JM, Olea JM, Morales R, Lozano L, Vicens JC. Emergency transvaginal hybrid natural orifice transluminal endoscopic surgery. Endoscopy. 2011 May;43(5):442-4. doi: 10.1055/s-0030-1256042. Epub 2010 Dec 16.

    PubMed 21165824
  • Noguera J, Dolz C, Cuadrado A, Olea J, Vilella A, Morales R. Hybrid transvaginal cholecystectomy, NOTES, and minilaparoscopy: analysis of a prospective clinical series. Surg Endosc. 2009 Apr;23(4):876-81. doi: 10.1007/s00464-008-0288-z. Epub 2009 Jan 1.

    PubMed 19118420
  • Noguera J, Tejada S, Tortajada C, Sanchez A, Munoz J. Prospective, randomized clinical trial comparing the use of a single-port device with that of a flexible endoscope with no other device for transumbilical cholecystectomy: LLATZER-FSIS pilot study. Surg Endosc. 2013 Nov;27(11):4284-90. doi: 10.1007/s00464-013-3044-y. Epub 2013 Jun 29.

    PubMed 23812286

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing SILS Cholecystectomy, FSIS cholecystectomy and Conventional laparoscopy in people with Cholelithiasis and Surgery, run by Jose F. Noguera at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical safety (time frame: During surgical intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01558414, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in